294 related articles for article (PubMed ID: 25342918)
1. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer.
Dong Y; Yu J; Ng SS
Cancer Manag Res; 2014; 6():405-22. PubMed ID: 25342918
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
4. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
6. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer.
Kubota N; Taniguchi F; Nyuya A; Umeda Y; Mori Y; Fujiwara T; Tanioka H; Tsuruta A; Yamaguchi Y; Nagasaka T
Oncol Lett; 2020 Apr; 19(4):2685-2694. PubMed ID: 32218819
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
[TBL] [Abstract][Full Text] [Related]
12. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
14. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
Yong FL; Law CW; Wang CW
BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
[TBL] [Abstract][Full Text] [Related]
15. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
[TBL] [Abstract][Full Text] [Related]
17. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
19. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
Ahadi A
Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
[TBL] [Abstract][Full Text] [Related]
20. Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.
Schee K; Lorenz S; Worren MM; Günther CC; Holden M; Hovig E; Fodstad O; Meza-Zepeda LA; Flatmark K
PLoS One; 2013; 8(6):e66165. PubMed ID: 23824282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]